Quote | Aligos Therapeutics Inc. (NASDAQ:ALGS)
Last: | $0.805 |
---|---|
Change Percent: | -2.9% |
Open: | $0.81 |
Close: | $0.829 |
High: | $0.829 |
Low: | $0.782 |
Volume: | 79,057 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Aligos Therapeutics Inc. (NASDAQ:ALGS)
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, wishes to express its c...
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that ma...
Message Board Posts | Aligos Therapeutics Inc. (NASDAQ:ALGS)
Subject | By | Source | When |
---|---|---|---|
$ALGS 4Q22 results12/31/22 cash=$126M4Q22 cash_burn=$16M: | DewDiligence | investorshub | 03/09/2023 9:45:09 PM |
$ALGS de-prioritizes HBV programreduces workforce 10%: | DewDiligence | investorshub | 02/08/2023 11:09:44 PM |
znewcar1: $ALGS 23% v4,7M c2.02 f42,815M H2.41 ML.84 gapNgo to HOD | znewcar1 | investorshangout | 01/17/2023 10:14:56 PM |
Might hit $3 today. | Laster | investorshub | 01/17/2023 3:08:08 PM |
Beautiful. Will pass $2 today. | Laster | investorshub | 01/17/2023 12:41:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Aligos Therapeutics Inc. Company Name:
ALGS Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, wishes to express its c...
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that ma...
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that do...